• Publications
  • Influence
MERRF: Clinical features, muscle biopsy and molecular genetics in Brazilian patients.
Myoclonic epilepsy with ragged red fibers (MERRF) is a mitochondrial disease that is characterized by myoclonic epilepsy with ragged red fibers (RRF) in muscle biopsies. The aim of this study was toExpand
  • 25
  • 5
Guidelines for the assessment and acceptance of potential brain-dead organ donors
Organ transplantation is the only alternative for many patients with terminal diseases. The increasing disproportion between the high demand for organ transplants and the low rate of transplantsExpand
  • 21
  • 4
  • PDF
Bone mineral density and serum levels of 25 OH vitamin D in chronic users of antiepileptic drugs.
The aim of this cross sectional study was to evaluate bone mineral density (BMD) and serum levels of 25-hydroxy vitamin D (25OHD) in a group of patients taking antiepileptic drugs (AED) for a seizureExpand
  • 80
  • 2
  • PDF
Clinical features of Psychogenic Nonepileptic Seizures (PNES): analysis of a Brazilian series
RATIONALE: An estimate of 3 million people present with the diagnosis of epilepsy in Brazil. Psychogenic Nonepileptic Seizures (PNES) are likely to occur in up to 2-33/100.000 people. Paradoxically,Expand
  • 23
  • 2
  • PDF
When should MELAS (Mitochondrial myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes) be the diagnosis?
Mitochondrial myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes (MELAS) is a rare mitochondrial disorder. Diagnostic criteria for MELAS include typical manifestations of theExpand
  • 27
  • 1
  • PDF
McArdle disease with rhabdomyolysis induced by rosuvastatin: case report.
The rosuvastatin inducing rhabdomyolysis in McArdle disease (MD) has not been reported to date. A 35-years-old man had exercise intolerance, muscular fatigue and cramps during physical activity sinceExpand
  • 18
  • 1
  • PDF
Bone density and bone turnover markers in patients with epilepsy on chronic antiepileptic drug therapy.
In this comparative, cross-sectional study, we evaluated 55 patients with epilepsy on chronic use of antiepileptic drugs (AED); [(38 females and 17 males, 35 +/- 6 years (25 to 47)] and compared toExpand
  • 18
  • 1
  • PDF
CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment
Phenytoin (PHT) is an antiepileptic drug widely used in the treatment of focal epilepsy and status epilepticus, and effective in controlling focal seizures with and without tonic–clonicExpand
  • 17
  • 1
  • PDF
CYP2C9 polymorphism in patients with epilepsy: genotypic frequency analyzes and phenytoin adverse reactions correlation.
OBJECTIVE CYP2C9 is a major enzyme in human drug metabolism and the polymorphism observed in the corresponding gene may affect therapeutic outcome during treatment. The distribution of variant CYP2C9Expand
  • 13
  • 1
  • PDF
Quality of life issues and occupational performance of persons with epilepsy.
Epilepsy causes restrictions in the performance of various daily activities. The aiming of this study was to investigate whether these restrictions affect the perceived quality of life. TheExpand
  • 15
  • 1
  • PDF